Aevi Genomic Medicine Inc. (GNMX) Climbed 5.96% or 0.09 To Price $1.6 On Thursday

Aevi Genomic Medicine Inc. (GNMX) climbed 5.96% or 0.09 to $1.6. It is near 52566 shares traded, which is 79.5% compare to the average total volume 66117. The market cap of GNMX is $94.94 million. The year to date change is 21.77%. The 52 week price range is from $0.98 to $2.65. Price of GNMX have changed 0.67% during last week. It have changed -2.47% over last month, -32.59% over last 3 months, 2.72% over last 6 months and 6.34% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GNMX is 1.79. It is 11.87% above current price. The 200-day Moving Averages for GNMX is 1.55. It is -3.13% below current price. The 52-week High is 2.65. It is 65.63% from the current price. The 52-week Low is 0.98. It is -38.75% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GNMX is 4.81 on 2018-04-30. Short % to float is 0.71%. There are some statistics of GNMX. It is has market cap $94.94 million. The share outstanding is 59.34 million. The average volume is 66117. The percent of top 15 Institution holding is 47.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GNMX is -105.84%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GNMX is -92.17%.


Share this post